Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$83.69M$83.69Mderived+41.1% vs Q4 2022 Net Income-$186.06M-$186.06MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$178,272,000N/M Operating Cash Flowderived-$130,819,000N/M Free Cash Flowderived-$132,972,000N/M Margins · derivedOperating margin-213.0%+42.4 pt vs Q4 2022
Net margin-222.3%+47.7 pt vs Q4 2022
ended Dec 31, 2023 · filed Feb 22, 2024 · 53 d after period end